How Bcl-2 helps cancer cells survive treatmentFebruary 21, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Study reveals potential target for mucositis, GVHD preventionFebruary 21, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesTransplantation
CAR T-cell therapy: The good and the badFebruary 20, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Making K-Ras cancers druggableFebruary 14, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
FDA approves ibrutinib for previously treated CLLFebruary 13, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Improving the efficacy of etoposideFebruary 11, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Allo-SCT can be effective in advanced SS, MFFebruary 7, 2014Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Combo may overcome drug resistance in ALLFebruary 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALL
Consortium study falls short of expectationsFebruary 4, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
TNFRII may play key role in CTCL, speaker saysJanuary 30, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Physical activity may cut death risk in male cancer survivorsJanuary 29, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues